Does RITUXIMAB Cause T-cell lymphoma recurrent? 10 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of T-cell lymphoma recurrent have been filed in association with RITUXIMAB (Rituxan). This represents 0.0% of all adverse event reports for RITUXIMAB.
10
Reports of T-cell lymphoma recurrent with RITUXIMAB
0.0%
of all RITUXIMAB reports
0
Deaths
0
Hospitalizations
How Dangerous Is T-cell lymphoma recurrent From RITUXIMAB?
Of the 10 reports.
Is T-cell lymphoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITUXIMAB. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does RITUXIMAB Cause?
Off label use (39,751)
Drug ineffective (32,186)
Rheumatoid arthritis (19,850)
Pain (16,675)
Fatigue (15,602)
Arthralgia (12,529)
Rash (12,102)
Drug intolerance (11,876)
Infusion related reaction (11,871)
Joint swelling (11,170)
What Other Drugs Cause T-cell lymphoma recurrent?
DOXORUBICIN (14)
PREDNISONE (14)
VINCRISTINE (13)
ENDOXAN INJ (10)
SULFAMETHOXAZOLE (10)
TRIMETHOPRIM (10)
CYCLOPHOSPHAMIDE (5)
Which RITUXIMAB Alternatives Have Lower T-cell lymphoma recurrent Risk?
RITUXIMAB vs RITUXIMAB-ABBS
RITUXIMAB vs RITUXIMAB-ARRX
RITUXIMAB vs RITUXIMAB-PVVR
RITUXIMAB vs RIVAROXABAN
RITUXIMAB vs RIVASTIGMINE